Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies.
Saved in:
| Title: | Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies. |
|---|---|
| Authors: | Jungova A; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic. Electronic address: jungovaa@fnplzen.cz., Stork M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Spicka I; 1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Radocha J; 4th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic., Minarik J; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic., Pavlicek P; Department of Internal Medicine and Haematology 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Mihalyova J; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Straub J; 1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Maisnar V; 4th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic., Pika T; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic., Dekojova T; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic., Soukup J; Department of Internal Medicine and Haematology 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Popkova T; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic., Mensikova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sedlák F; 1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Pospiskova J; 4th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic., Boichuk I; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Krhovska P; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic., Stopka T; 1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Jindra P; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic., Jelínek T; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic., Knechtová Z; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Capounova V; 4th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic., Latal V; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic., Muronova L; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic., Heindorfer A; Department of Hematology, Liberec Regional Hospital, Liberec, Czech Republic., Ullrychova J; Department of Hematology, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic., Sykora M; Department of Hematology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic., Kessler P; Department of Hematology, Hospital Pelhrimov, Pelhrimov, Czech Republic., Hajek R; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic; Department of Hemato-Oncology, Faculty of Medicine University of Ostrava, Ostrava, Czech Republic. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Apr; Vol. 26 (4), pp. e470-e482. Date of Electronic Publication: 2025 Nov 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41339214 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jungova+A%22">Jungova A</searchLink>; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic. Electronic address: jungovaa@fnplzen.cz.<br /><searchLink fieldCode="AU" term="%22Stork+M%22">Stork M</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Spicka+I%22">Spicka I</searchLink>; 1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Radocha+J%22">Radocha J</searchLink>; 4th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Minarik+J%22">Minarik J</searchLink>; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pavlicek+P%22">Pavlicek P</searchLink>; Department of Internal Medicine and Haematology 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Mihalyova+J%22">Mihalyova J</searchLink>; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pour+L%22">Pour L</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Straub+J%22">Straub J</searchLink>; 1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Maisnar+V%22">Maisnar V</searchLink>; 4th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pika+T%22">Pika T</searchLink>; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Dekojova+T%22">Dekojova T</searchLink>; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Soukup+J%22">Soukup J</searchLink>; Department of Internal Medicine and Haematology 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Popkova+T%22">Popkova T</searchLink>; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Mensikova+K%22">Mensikova K</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sedlák+F%22">Sedlák F</searchLink>; 1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pospiskova+J%22">Pospiskova J</searchLink>; 4th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Boichuk+I%22">Boichuk I</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Krhovska+P%22">Krhovska P</searchLink>; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Stopka+T%22">Stopka T</searchLink>; 1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Jindra+P%22">Jindra P</searchLink>; Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Jelínek+T%22">Jelínek T</searchLink>; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Knechtová+Z%22">Knechtová Z</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Capounova+V%22">Capounova V</searchLink>; 4th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Latal+V%22">Latal V</searchLink>; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Muronova+L%22">Muronova L</searchLink>; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Heindorfer+A%22">Heindorfer A</searchLink>; Department of Hematology, Liberec Regional Hospital, Liberec, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Ullrychova+J%22">Ullrychova J</searchLink>; Department of Hematology, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sykora+M%22">Sykora M</searchLink>; Department of Hematology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kessler+P%22">Kessler P</searchLink>; Department of Hematology, Hospital Pelhrimov, Pelhrimov, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hajek+R%22">Hajek R</searchLink>; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic; Department of Hemato-Oncology, Faculty of Medicine University of Ostrava, Ostrava, Czech Republic. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2026 Apr; Vol. 26 (4), pp. e470-e482. <i>Date of Electronic Publication: </i>2025 Nov 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41339214 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clml.2025.10.022 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e470 Titles: – TitleFull: Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jungova A – PersonEntity: Name: NameFull: Stork M – PersonEntity: Name: NameFull: Spicka I – PersonEntity: Name: NameFull: Radocha J – PersonEntity: Name: NameFull: Minarik J – PersonEntity: Name: NameFull: Pavlicek P – PersonEntity: Name: NameFull: Mihalyova J – PersonEntity: Name: NameFull: Pour L – PersonEntity: Name: NameFull: Straub J – PersonEntity: Name: NameFull: Maisnar V – PersonEntity: Name: NameFull: Pika T – PersonEntity: Name: NameFull: Dekojova T – PersonEntity: Name: NameFull: Soukup J – PersonEntity: Name: NameFull: Popkova T – PersonEntity: Name: NameFull: Mensikova K – PersonEntity: Name: NameFull: Sedlák F – PersonEntity: Name: NameFull: Pospiskova J – PersonEntity: Name: NameFull: Boichuk I – PersonEntity: Name: NameFull: Krhovska P – PersonEntity: Name: NameFull: Stopka T – PersonEntity: Name: NameFull: Jindra P – PersonEntity: Name: NameFull: Jelínek T – PersonEntity: Name: NameFull: Knechtová Z – PersonEntity: Name: NameFull: Capounova V – PersonEntity: Name: NameFull: Latal V – PersonEntity: Name: NameFull: Muronova L – PersonEntity: Name: NameFull: Heindorfer A – PersonEntity: Name: NameFull: Ullrychova J – PersonEntity: Name: NameFull: Sykora M – PersonEntity: Name: NameFull: Kessler P – PersonEntity: Name: NameFull: Hajek R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 26 – Type: issue Value: 4 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |